La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Stepan Croissance future

Future contrôle des critères 3/6

Stepan is forecast to grow earnings and revenue by 71.3% and 6% per annum respectively while EPS is expected to grow by 70.7% per annum.

Informations clés

71.3%

Taux de croissance des bénéfices

70.7%

Taux de croissance du BPA

Chemicals croissance des bénéfices	16.9%
Taux de croissance des recettes	6.0%
Rendement futur des capitaux propres	n/a
Couverture par les analystes	Low
Dernière mise à jour	01 Aug 2024

Mises à jour récentes de la croissance future

Recent updates

Stepan Company: Don't Try To Catch The Falling Knife, Still Potentially Overvalued

Sep 17

Stepan (NYSE:SCL) Has A Somewhat Strained Balance Sheet

Aug 31

Stepan's Shares Are Reaching Even More Appealing Prices

Aug 28

Are Investors Undervaluing Stepan Company (NYSE:SCL) By 31%?

Jul 18

Investors Could Be Concerned With Stepan's (NYSE:SCL) Returns On Capital

Jul 06

Stepan Company: A Downward Revision Is Warranted

Jun 09

Is Stepan (NYSE:SCL) Using Too Much Debt?

May 23

At US$92.20, Is Stepan Company (NYSE:SCL) Worth Looking At Closely?

May 01

Stepan (NYSE:SCL) Ticks All The Boxes When It Comes To Earnings Growth

Mar 25

Returns On Capital At Stepan (NYSE:SCL) Have Stalled

Mar 08

Stepan Q4 2022 Earnings Preview

Feb 15

Here's Why Stepan (NYSE:SCL) Can Manage Its Debt Responsibly

Feb 02

Stepan Company (NYSE:SCL) Shares Could Be 30% Below Their Intrinsic Value Estimate

Jan 05

Stepan Company: Expect Outperformance To Continue

Jan 03

Stepan (NYSE:SCL) Has Some Way To Go To Become A Multi-Bagger

Dec 03

Stepan (NYSE:SCL) Is Paying Out A Larger Dividend Than Last Year

Nov 17

Stepan Company: Consistent Dividend Growth In Times Of Uncertainty

Oct 13

Stepan Company's (NYSE:SCL) Intrinsic Value Is Potentially 90% Above Its Share Price

Sep 20

Prévisions de croissance des bénéfices et des revenus

NYSE:SCL - Estimations futures des analystes et données financières antérieures (USD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
12/31/2026	2,625	N/A	179	N/A	1
12/31/2025	2,459	98	168	N/A	3
12/31/2024	2,243	49	62	N/A	3
6/30/2024	2,202	35	50	210	N/A
3/31/2024	2,226	38	90	288	N/A
12/31/2023	2,326	40	-85	175	N/A
9/30/2023	2,421	52	-118	192	N/A
6/30/2023	2,578	79	-174	158	N/A
3/31/2023	2,749	118	-224	110	N/A
12/31/2022	2,773	147	-141	161	N/A
9/30/2022	2,756	153	-155	126	N/A
6/30/2022	2,640	151	-163	86	N/A
3/31/2022	2,484	142	-154	63	N/A
12/31/2021	2,346	138	-126	72	N/A
9/30/2021	2,231	151	-49	115	N/A
6/30/2021	2,092	147	52	201	N/A
3/31/2021	1,958	140	96	230	N/A
12/31/2020	1,870	127	107	235	N/A
9/30/2020	1,820	118	106	227	N/A
6/30/2020	1,807	111	81	198	N/A
3/31/2020	1,820	106	92	208	N/A
12/31/2019	1,859	103	113	218	N/A
9/30/2019	1,880	105	113	208	N/A
6/30/2019	1,937	101	108	196	N/A
3/31/2019	1,984	104	90	175	N/A
12/31/2018	1,994	111	84	171	N/A
9/30/2018	2,001	97	87	170	N/A
6/30/2018	1,981	97	108	192	N/A
3/31/2018	1,956	92	N/A	197	N/A
12/31/2017	1,925	101	N/A	199	N/A
9/30/2017	1,872	90	N/A	217	N/A
6/30/2017	1,829	90	N/A	197	N/A
3/31/2017	1,789	90	N/A	217	N/A
12/31/2016	1,766	86	N/A	212	N/A
9/30/2016	1,765	91	N/A	180	N/A
6/30/2016	1,764	94	N/A	182	N/A
3/31/2016	1,762	83	N/A	148	N/A
12/31/2015	1,776	76	N/A	184	N/A
9/30/2015	1,811	69	N/A	161	N/A
6/30/2015	1,859	58	N/A	145	N/A
3/31/2015	1,910	65	N/A	125	N/A
12/31/2014	1,927	57	N/A	83	N/A
9/30/2014	1,947	62	N/A	114	N/A
6/30/2014	1,931	68	N/A	124	N/A
3/31/2014	1,902	67	N/A	151	N/A
12/31/2013	1,881	73	N/A	150	N/A
9/30/2013	1,834	78	N/A	113	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: SCL's forecast earnings growth (71.3% per year) is above the savings rate (2.5%).

Bénéfices vs marché: SCL's earnings (71.3% per year) are forecast to grow faster than the US market (15.1% per year).

Croissance élevée des bénéfices: SCL's earnings are expected to grow significantly over the next 3 years.

Chiffre d'affaires vs marché: SCL's revenue (6% per year) is forecast to grow slower than the US market (8.8% per year).

Croissance élevée des revenus: SCL's revenue (6% per year) is forecast to grow slower than 20% per year.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Insufficient data to determine if SCL's Return on Equity is forecast to be high in 3 years time

Stepan Croissance future

Future contrôle des critères 3/6

Informations clés

Mises à jour récentes de la croissance future

Consensus EPS estimates fall by 22%

Consensus EPS estimates fall by 33%

Consensus EPS estimates fall by 15%

Price target decreased by 23% to US$95.00

Consensus EPS estimates fall by 34%

Consensus EPS estimates fall by 15%

Recent updates

Stepan (NYSE:SCL) Takes On Some Risk With Its Use Of Debt

Investor sentiment deteriorates as stock falls 19%

Consensus EPS estimates fall by 22%

Second quarter dividend of US$0.38 announced

New minor risk - Financial position

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Stepan Company Declares Quarterly Cash Dividend, Payable on September 13, 2024

Stepan Company Is Making Great Progress

When Should You Buy Stepan Company (NYSE:SCL)?

Stepan Company to Report Q2, 2024 Results on Jul 31, 2024

There Are Reasons To Feel Uneasy About Stepan's (NYSE:SCL) Returns On Capital

Upcoming dividend of US$0.38 per share

First quarter dividend of US$0.38 announced

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Stepan Company Declares Quarterly Cash Dividend, Payable on June 14, 2024

Stepan Company to Report Q1, 2024 Results on Apr 30, 2024

Stepan Company's (NYSE:SCL) Price In Tune With Earnings

Stepan Company, Annual General Meeting, Apr 30, 2024

Is There Now An Opportunity In Stepan Company (NYSE:SCL)?

Non-Executive Chairman recently sold US$261k worth of stock

Consensus EPS estimates fall by 33%

Non-Executive Chairman notifies of intention to sell stock

Fourth quarter dividend of US$0.38 announced

Full year 2023 earnings: EPS misses analyst expectations

Stepan Declares Quarterly Cash Dividend, Payable on March 15, 2024

Is Stepan (NYSE:SCL) Using Too Much Debt?

Stepan Company: It's Wise To Remain Cautious

Stepan Company Appoints Susan M. Lewis as Director

Non-Executive Chairman exercised options and sold US$694k worth of stock

Insufficient new directors

Stepan Company to Report Q4, 2023 Results on Feb 20, 2024

With Stepan Company (NYSE:SCL) It Looks Like You'll Get What You Pay For

Capital Allocation Trends At Stepan (NYSE:SCL) Aren't Ideal

Are Investors Undervaluing Stepan Company (NYSE:SCL) By 27%?

Stepan Company: An Unfortunate Development Resulting In An Upside

Upcoming dividend of US$0.38 per share at 1.9% yield

Consensus EPS estimates fall by 15%

New minor risk - Financial position

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Stepan Company Declares Quarterly Cash Dividend, Payable on December15, 2023

Price target decreased by 23% to US$95.00

When Should You Buy Stepan Company (NYSE:SCL)?

Stepan Company to Report Q3, 2023 Results on Oct 18, 2023

Stepan Company: Don't Try To Catch The Falling Knife, Still Potentially Overvalued

Stepan (NYSE:SCL) Has A Somewhat Strained Balance Sheet

Stepan's Shares Are Reaching Even More Appealing Prices

Upcoming dividend of US$0.36 per share at 1.7% yield

Non-Executive Chairman notifies of intention to sell stock

Consensus EPS estimates fall by 34%

Stepan Company Declares Quarterly Cash Dividend, Payable on September 15, 2023

New minor risk - Profit margin trend

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Are Investors Undervaluing Stepan Company (NYSE:SCL) By 31%?

Consensus EPS estimates fall by 15%

Investors Could Be Concerned With Stepan's (NYSE:SCL) Returns On Capital

New minor risk - Dividend sustainability

Stepan Company to Report Q2, 2023 Results on Jul 26, 2023

Stepan Company Announces Retirement of Arthur W. Mergner, Executive Vice President, Effective July 3, 2023

Stepan Company: A Downward Revision Is Warranted

Executive Vice President exercised options and sold US$340k worth of stock

Is Stepan (NYSE:SCL) Using Too Much Debt?

Upcoming dividend of US$0.36 per share at 1.6% yield

Lead Independent Director notifies of intention to sell stock

CEO, President & Director recently sold US$180k worth of stock

CEO, President & Director notifies of intention to sell stock

At US$92.20, Is Stepan Company (NYSE:SCL) Worth Looking At Closely?

First quarter 2023 earnings: EPS misses analyst expectations

Price target decreased by 8.5% to US$129

Stepan (NYSE:SCL) Ticks All The Boxes When It Comes To Earnings Growth